sp dha 40

Docosahexaenoic acid transfer into human milk after dietary supplementation: a randomized clinical trial.

Nataša Fidler, Thorsten Sauerwald,Anja Pohl,Hans Demmelmair and Berthold Koletzko1

Publication: Journal of Lipid Research http://www.jlr.org/content/41/9/1376.long

The long-chain polyunsaturated fatty acid , Docosahexaenoic acid (DHA) is an essential structural component in tissue membranes of the human body and is highly concentrated in brain and retina. Inadequate early intake may affect later visual function and neuro development .

Hence Docosahexaenoic acid (DHA) is important for infant development. The authors studied the effects of DHA supplementation on the fatty acid composition of human milk and the secretion of dietary 13C- labeled fatty acids, including DHA, into human milk. Dietary DHA supplementation increases the DHA content in human milk. DHA transfer from the diet into human milk is comparable to palmitic and oleic acid transfer.

This study shows that dietary DHA intake has a specific effect on breast milk DHA content.

Prenatal Docosahexaenoic Acid Supplementation and Infant Morbidity: Randomized Controlled Trial

Beth Imhoff-Kunsch, MPH, PhD, Aryeh D. Stein, MPH, PhD, Reynaldo,Martorell, PhD,Socorro Parra- Cabrera, PhD, Isabelle Romieu, MD, MPH,ScD, and Usha Ramakrishnan, PhD

Publication : Pediatrics http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164093/pdf/zpee505.pdf

The present study reveals the probable effects of prenatal DHA supplementation on infant morbidity. The researchers have concluded that DHA supplementation during pregnancy decreased the occurrence of colds in children at one month and influenced illness symptom duration at one, three, and six months . This in-depth and pains taking research findings contribute to the accumulating evidence base for a relationship of prenatal n-3 PUFA nutrition to the development of fetal and neonatal immune function.

Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico.

Ramakrishnan U, Stein AD, Parra-Cabrera S, Wang M, Imhoff-Kunsch B, Juárez-Márquez S, Rivera J, Martorell R.

Publication : Food Nutr Bull . http://www.ncbi.nlm.nih.gov/pubmed/20715595


This informative article based on research conducted in Mexico suggests that prenatal DHA supplementation of primigravid women may result in increased birth size in a population where dietary DHA intakes are very low.


Tamás Decsi, Cristina Campoy, Berthold Koletzko

Publication: Adv Exp Med Biol. http://eknygos.lsmuni.lt/springer/128/109-113.pdf

The authors have carried out an extensive study on the beneficial effects of DHA supplementation in a dose of 400mg/day from the 20th week onwards during pregnancy. They conclude that it further enhances the fatty acid composition of cord blood lipids in addition to the enhancement of maternal and placental blood lipids. Hence the present results indicate that 400 mg/day might be an effective dosage of DHA supplementation during pregnancy.

About Curegarden

Curegarden represents a dream. A dream of sharing a happier, healthier body and quality of life with the use of nature's best ingredients. Botanics, when extracted for their bio-active compounds, offer a most effective approach to improving well-being and quality of life. It is based on the belief that botanical of the highest quality would have a positive effect — without any negative side effects — on people's health. Over the years,we have seen and experienced personally the wonderful benefits of these high quality botanical products and are delighted to share them with others.

About Arjuna Naturals

Arjuna Natural Ltd is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for over two decades. With customers in around 40 countries, the company has close to 50 patents to its credit of which majority are commercialized globally. The company has R&D tie ups with international universities from Australia, US and Japan. The highly advanced R&D unit at Arjuna is a complete research facility for phytochemistry, pharmacokinetics, formulation and development, pre-clinical and clinical studies.